Valuation: Vivos Therapeutics, Inc.

Market Cap 5.74M 5.01M 4.64M 4.25M 8.05M 553M 8.19M 55.29M 21.72M 270M 21.54M 21.07M 932M P/E 2026 *
-0.3x
P/E 2027 * -0.52x
Enterprise Value 5.74M 5.01M 4.64M 4.25M 8.05M 553M 8.19M 55.29M 21.72M 270M 21.54M 21.07M 932M EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.17x
Free-Float
74.28%
Yield 2026 *
-
Yield 2027 * -
1 day-0.02%
1 week-11.34%
Current month-9.17%
1 month-24.19%
3 months-62.13%
6 months-80.06%
Current year-79.67%
1 week 0.4
Extreme 0.4031
0.47
1 month 0.38
Extreme 0.383
0.55
Current year 0.38
Extreme 0.383
2.69
1 year 0.38
Extreme 0.383
5.95
3 years 0.38
Extreme 0.383
48.79
5 years 0.38
Extreme 0.383
177.25
10 years 0.38
Extreme 0.383
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 2016-08-31
Chief Executive Officer 68 2016-08-31
Director TitleAgeSince
Chairman 68 2020-05-31
Director/Board Member 87 2020-05-31
Director/Board Member 59 2020-05-31
Date Insider Type Main position Quantity % Market Cap.
2/4/26 Other

Director

3,997 0.0424%
11/26/24 Other

Chief Executive Officer

315,421 6.6191%
11/26/24 Other

Chief Financial Officer

149,533 3.1380%
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%-11.34%-93.20%-94.78% 5.74M
+0.91%+0.52%+36.34%+1.48% 12.57B
+2.18%+3.84%+13.10%+14.08% 5.96B
+2.54%-0.45%+54.38%+29.23% 5.66B
-1.41%+6.41%-28.11%+19.24% 4.38B
+2.98%+5.51% - - 4.46B
+1.35%+8.96%-20.34%-21.58% 4.1B
+2.43%-5.03%-1.02%-58.89% 1.9B
+0.79%-1.40%-0.63%+248.14% 1.87B
-0.98%-0.33%+56.31%-4.13% 1.56B
Average +1.08%-0.43%+1.87%+14.75% 4.25B
Weighted average by Cap. +1.32%+1.16%+18.96%+15.99%

Financials

2026 *2027 *
Net sales 24.06M 21.03M 19.45M 17.84M 33.77M 2.32B 34.36M 232M 91.1M 1.13B 90.34M 88.35M 3.91B 34.09M 29.8M 27.56M 25.29M 47.86M 3.28B 48.69M 329M 129M 1.6B 128M 125M 5.54B
Net income -23.82M -20.82M -19.25M -17.67M -33.44M -2.29B -34.02M -230M -90.19M -1.12B -89.44M -87.47M -3.87B -13.78M -12.05M -11.14M -10.22M -19.35M -1.33B -19.69M -133M -52.2M -649M -51.77M -50.63M -2.24B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
26-07-16 US$0.4128 -0.02% 181,547
26-07-15 US$0.4129 +0.78% 89,416
26-07-14 US$0.4097 -2.36% 246,280
26-07-13 US$0.4196 -2.87% 173,639
26-07-10 US$0.4320 -7.22% 173,885
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4128USD
Average target price
2.117USD
Spread / Average Target
+412.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock